Ocular Therapeutix OCUL
NASDAQ OCUL
$6.62 +0.14 (+2.16%)
As of: Oct 22, 2026 · 10:52 AM EDT

Ocular Therapeutix (OCUL) Short-Term Debt issuances (2023)

Updated

Ocular Therapeutix (OCUL) recorded Short-Term Debt issuances of $2 million in FY2023.

Analysis

Ocular Therapeutix (OCUL) Short-Term Debt issuances (2023) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ST Debt Issuance (Qtr)
1 Eli Lilly 1,166.78 Bn 1,135.37 Bn 19.71 Bn -
2 Johnson & Johnson 635.34 Bn 553.86 Bn 17.26 Bn 707.00 Mn
3 AbbVie 503.48 Bn 476.60 Bn 12.70 Bn -
4 Merck 377.08 Bn 331.46 Bn 12.21 Bn -
5 Novartis Ag 304.13 Bn 268.12 Bn 11.24 Bn -
6 Astrazeneca 267.48 Bn 241.16 Bn 12.86 Bn -
7 Amgen 241.75 Bn 197.15 Bn 7.24 Bn -
8 Gilead Sciences 194.09 Bn 168.29 Bn 6.22 Bn -
9 Pfizer 172.59 Bn 119.24 Bn 10.94 Bn -
10 Ocular Therapeutix 1.49 Bn -860.24 Mn 11.46 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 2.00 Mn
API Access

Ocular Therapeutix Short-Term Debt issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=short-term-debt-issuances&ticker=OCUL&period=max&api_key=YOUR_API_KEY